(11) A study investigated the potential of GHK to reduce levels of reactive oxygen species in cell cultures
Back Capozzi, ME, DiMarchi, RD, Tschp, MH, et al (13 June 2019) Targeting the incretin/glucagon system with triagonists to treat diabetes', Endocrine Reviews , 39/5, 719-38
Systematic reviews suggest that GLP-1 RAs may, in fact, exert neuroprotective effects in diabetes-related neurological complications, although recent pharmacovigilance analyses have identified various neurological adverse events temporally associated with GLP-1 RAs, emphasizing the need for continued surveillance [11]
- Really interesting perspective published in Obesity by Abigail Lodrigues and colleagues
Gentle treatments may resume with approval